News

More than a century after Aldred Scott Warthin, M.D., Ph.D., a pathologist at the University of Michigan, first suspected heredity lay behind one family’s numerous cancers, scientists have begun testing two experimental… Learn more

Despite intense research, liver cancer prevention remains a challenge. Current efforts are directed at underlying conditions that can significantly raise an individual’s risk, including hepatitis C infection, for which… Learn more

Eleven DCP/PREVENT presentations were delivered at the 2023 AACR Annual meeting, including: five poster sessions, one informational session with four staff from the NCI Division of Cancer Prevention, and two staff sessions… Learn more

Early-onset colorectal cancer is considered relatively rare, but both incidence and mortality rates are increasing in people under age 50. NCI recently issued a special research request for grant applications in areas such… Learn more

The executive summary of the second PARTNRS (Primary Care Alliance in Research Trials Involving NCORP Sites) Workshop is now available. PARTNRS is a strategic initiative to encourage and forge partnerships between oncologists and primary care providers to promote patient accrual into cancer… Learn more

Researchers have recruited the first vaccine candidates to one of two new prevention trials that seek to immunize high-risk individuals against cancers associated with Lynch syndrome, the most common cause of hereditary colorectal cancer. Individuals who inherit the condition have an estimated… Learn more

We present ULACNet-302 Estudio Oportunidad: An opportunity to improve the health of women living with HIV, Recruitment strategies for the ULACNet 201 study in Puerto Rico, and Use of a mobile application as a strategy to… Learn more

The National Cancer Institute’s (NCI’s) Board of Scientific Advisors (BSA) recently approved two new concept proposals aimed at expanding potential prevention interventions.